Electroacupuncture for the Treatment of Functional Constipation
A Randomized Controlled Trial of Acupuncture to Treat Functional Constipation
1 other identifier
interventional
243
1 country
3
Brief Summary
The purpose of this study is to investigate the effect of electroacupuncture on functional constipation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Feb 2013
Typical duration for phase_1
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 23, 2013
CompletedFirst Posted
Study publicly available on registry
February 1, 2013
CompletedStudy Start
First participant enrolled
February 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedMarch 19, 2015
April 1, 2014
2.8 years
January 23, 2013
March 17, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
number of defecation per week
3 years
Study Arms (3)
mosapride
ACTIVE COMPARATORmosapride
Electro-acupuncture
EXPERIMENTALElectro-acupuncture
mosapride + sham acupuncture
SHAM COMPARATORmosapride + sham acupuncture
Interventions
sterile, disposable needles with a length of 40 mm and a diameter of 0.25 mm (Dongbang® Acupuncture Inc, Korea)
Mosapride Citrate tablet(5mg),Dainippon Sumitomo pharmaceutical Co.Ltd,Japan
Eligibility Criteria
You may qualify if:
- functional constipation according to the Roman Ⅲ standard;
- aged between 18 and 65 years old
You may not qualify if:
- unconsciousness, psychosis or can't express subjective symptoms;
- pregnant women or women in lactation period;
- serious diseases of the heart, liver, kidney, and others;
- bleeding disorders.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Hospital of Huazhong University of Science and Technology
Wuhan, Hubei, 430000, China
Hubei Provincial Hospital of TCM
Wuhan, Hubei, 430000, China
Institute of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, 430030, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Xiaohu Xu, Doctor
HUST(Huazhong University of Science and Technology) Hospital
- PRINCIPAL INVESTIGATOR
Feng Hu, Master
Hubei Hospital of Traditional Chinese Medicine
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor
Study Record Dates
First Submitted
January 23, 2013
First Posted
February 1, 2013
Study Start
February 1, 2013
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
March 19, 2015
Record last verified: 2014-04